ARISE - African Research and Innovative Initiative for Sickle cell Education: Improving Research Capacity for Service Improvement


Logo ARISE.jpg

Creating a multidisciplinary staff exchange programme between researchers and other relevant staff members to share and spread the best practices in Newborn Screening, diagnosis and treatment of Sickle Cell Disease (SCD), leading to improvement disease outcome.
A large secondments plan between EU and non-EU countries will enable collaborative research and training initiatives, covering the among them Sickle Cell Disease prevalence, genotypes and phenotypes, existing “best practices” for Newborn Screening and early diagnosis, lab diagnosis and quality assurance systems for population screening etc.
The multi-directional exchanges will foster new collaborative, institutional partnerships, promote scientific and technological Sickle Cell Disease (SCD) research cooperation between Africa, Europe and USA and build capacity towards sustainable improvement in health-related.


  • Fondazione Per La Ricerca Farmacologica Gianni Benzi Onlus (Italy)
  • Guys And St Thomas' Nhs Foundationtrust (UK)
  • Azienda Ospedale Universita Padova (Italy)
  • Institut National De La Sante Et De La Recherche Medicale Inserm (France)
  • Geniko Laiko Nosokomeio Athinon*General Hospital of Athens Laiko (Greece)
  • Kypriako Idryma Erevnon Gia Ti Myiki Distrofia (Cyprus)
  • University College London (UK)
  • The Royal College of Pathologists (UK)
  • London School of Hygiene and Tropical Medicine Royal Charter (UK)
  • Universita Degli Studi Di Padova (Italy)
  • Universita Degli Studi Di Udine (Italy)
  • Universita Degli Studi Della Campania Luigi Vanvitelli (Italy)
  • Instituto Politecnico De Lisbona (Portugal)

Importo del progetto

Importo totale del progetto: 2.106.800,00 euro
Importo del progetto Uniud:  29.400,00 euro 


Data avvio progetto: 01/01/2019
Data conclusione progetto: 31/10/2024 

Link del progetto